Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways

29 Nov 2019

Abstract excerpt

Schizophrenia is a chronic, severe and disabling psychiatric disorder with a complex neurobiological pathophysiology that translates into an ambiguous aetiology. The lack of consensus regarding the pathogenesis of this ailment has increased the need to explore new research lines in this regard. Advances in “omics” sciences, such as proteomics, promotes new approaches to better understand the molecular basis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Gut microbiota and health
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31849731
DOI: 10.3389/fpsyt.2019.00885

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune PathwaysPMID 31849731Read ↗

The difference in serum proteomes in schizophrenia and bipolar disorderSemantic proximity Read ↗

Application and integration of bioinformatic strategies towards central and peripheral proteomic profiling for diagnosis and drug discovery in schizophreniaSemantic proximity Read ↗

Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Semantic proximity Read ↗

Analysis of Circulating Exosomes Reveals a Peripheral Signature of Astrocytic Pathology in SchizophreniaSemantic proximity Read ↗

Proteome analysis of schizophrenia brain tissueSemantic proximity Read ↗

Cerebrospinal fluid proteomics reveals synaptic and immune dysregulation in treatment-resistant schizophreniaSemantic proximity Read ↗

Proteomics Research in SchizophreniaSemantic proximity Read ↗

Alterations in the Expression Levels of miR-9-5p and miR-4467 in Peripheral Blood of Patients with First-Episode SchizophreniaSemantic proximity Read ↗

Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severitySemantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

Proteomics in molecular medicine: applications in central nervous systems disorders.Semantic proximity Read ↗

Plasma Levels of Neuron- and Astrocyte-Derived Exosomal Amyloid Beta1-42, Amyloid Beta1-40, and Phosphorylated Tau Levels in Schizophrenia Patients and Non-psychiatric Comparison Subjects: Relationships With Cognitive Functioning and PsychopathologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.